Australia and New Zealand Remote Healthcare Market to Grow at a CAGR of 27.3% to reach US$ 8,317.66 million from 2022 to 2028

Australia and New Zealand Remote Healthcare Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Service (Real Time Virtual Health, Remote Patient Monitoring, and Tele-ICUs); and End-User (Healthcare Providers, Patients, Payers, Employer Groups and Government Organizations)

  • Report Code : TIPRE00029787
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 132
Buy Now

The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021 and is expected to reach US$ 8,317.66 million by 2028; it is anticipated to record a CAGR of 27.3% from 2022 to 2028.

Remote health is revolutionizing the healthcare industry and can be seen as a subset of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time. Moreover, it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.

The growth of the Australia and New Zealand remote healthcare market is attributed to the factors such as rise in the use of telehealth and virtual care during the COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns are hampering the market growth.

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Increase in Number of Digital Health Users

People in Australia and New Zealand are already using digital apps, tools, and services as the preferred way to manage their personal and professional lives. Telehealth remains a constant part of Australia’s health system, which has enhanced access to quality health care for Australians. More than 100 million telehealth services have been provided to 17 million Australians since March 2020. Digital health is an umbrella term indicating a range of technologies that can be used to treat patients and gather and share a person’s health information. Digital health includes mobile health, electronic prescribing, electronic health records, telemedicine and telehealth, and robotics and artificial intelligence.

According to the Australian Digital Health Agency (ADHA) statistics, the number of records with data in them on My Health Record grew from 5.39 million in January 2019 to 22.31 million in December 2021, with more than 537 million documents uploaded. Monthly views of content on the platform were 476% higher between July and December 2021 (6.08 million avg/month) compared with pre-pandemic views from March 2019 to February 2020 (1.06 million avg/month).

Now and in the future, high-quality digital information remains an important aspect of health care. In particular, improving standardizing and health data development could lead to better information to use and share within the health care system. Thus, the improving user experience in digital health is expected to catalyze the growth of the Australia and New Zealand remote healthcare market.

The COVID-19 outbreak positively impacted the growth of the remote healthcare market in Asia Pacific. The Government of Australia expanded Australians' access to telehealth in March 2020 to minimize the risk of community transmission. Over 200 telehealth services were made permanently available. The MBS video and telephone services are available nationally from medical specialists, GPs, and other health professionals. In July 2022, a new temporary telehealth service was introduced that allows longer telephone consultations for patients who have received a positive COVID-19 test. Also, virtual health care (VHC) COVID-19 home monitoring for patients with mild to moderate illness was adopted as a central strategy in Australia to reduce pressure away from acute health systems. Thus, the growing government support for remote patient monitoring for the treatment of COVID-19 is supporting the Australia and New Zealand remote healthcare market.

Service-Based Insights

Based on service, the remote healthcare market is segmented into real time virtual health, remote patient monitoring, and tele-ICUs. The remote patient monitoring segment held the largest market share in 2021. However, the real time virtual health segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028). Remote patient monitoring (RPM) is a method of healthcare delivery through digital health platforms that enables patients to be evaluated outside traditional healthcare settings, in their homes, or community. RPM can significantly reduce a patient's time in the hospital and allow them to recover under monitoring at home. RPM is especially effective for chronic conditions such as heart disease, chronic obstructive pulmonary disease (COPD), and asthma. Also, a rise in product development is likely to favor the market growth. During the pandemic, “COVIDWatch” was developed by the University of Pennsylvania's health system. It is an RPM program that uses automated twice-daily short message service questionnaires to track symptoms.

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
End User-Based Insights

Based on end user, the remote healthcare market is segmented into healthcare providers, patients, payers, and employer groups & government organizations. The healthcare providers segment held the largest share of the market in 2021. However, the payers segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028).

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Australia and New Zealand Remote Healthcare Market: Strategic Insights

australia-and-new-zealand-remote-healthcare-market
Market Size Value inUS$ 1,545.82 Million in 2021
Market Size Value byUS$ 8,317.66 Million by 2028
Growth rateCAGR of 27.3% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Various companies in the Australia and New Zealand remote healthcare market focus on the collaboration strategy to expand their clientele, which, in turn, helps them maintain their brand name across the world.

The Australia and New Zealand remote healthcare market is segmented based on service and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and tele-ICU. In terms of end user, the market is segmented into healthcare providers, patients, payers, and employer groups and government organizations.

Company Profiles

  • BIOTRONIK SE & Co KG
  • Koninklijke Philips NV
  • Hicuity Health Inc
  • Medtronic Plc
  • American Well Corp
  • Teladoc Health Inc
  • BioTelemetry Inc
  • Abbott Laboratories
  • GE HealthCare
  • Siemens Healthcare GmbH
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Service, and End-User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Australia and New Zealand

Frequently Asked Questions


What is remote healthcare?

Remote health is revolutionizing the healthcare industry and can be seen as a sub-set of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time, along with which it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.

What are the driving factors for the Australia and New Zealand remote healthcare market?

The factors that are driving the growth of market are rise in use of telehealth and virtual care during COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns is the major factor hindering the remote healthcare market growth.

Who are the major players in Australia and New Zealand remote healthcare market?

The remote healthcare market majorly consists of the players, such as BIOTRONIK SE & Co KG, Koninklijke Philips NV, Hicuity Health Inc, Medtronic Plc, American Well Corp, Teladoc Health Inc, BioTelemetry Inc, Abbott Laboratories, GE HealthCare, and Siemens Healthcare GmbH among others.

What will be the CAGR of the Australia and New Zealand remote healthcare market during the forecast period?

The market is estimated to grow at a CAGR of 27.3% during the forecast period.

What was the estimated Australia and New Zealand remote healthcare market size in 2021?

The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021.

What are the growth estimates for the Australia and New Zealand remote healthcare market till 2028?

The Australia and New Zealand remote healthcare market is expected to reach US$ 8,317.66 million by 2028.

Which segment is dominating the Australia and New Zealand remote healthcare market based on service?

The Australia and New Zealand remote healthcare market is analyzed based on service type and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and Tele-ICUs. In 2021, the remote patient monitoring segment held the largest share of the market. However, the real time virtual health segment is anticipated to register the highest CAGR during the forecast period.

Which country accounts for major market share in 2021 in Australia and New Zealand remote healthcare market?

Australia accounts for the major market share of remote healthcare market in 2021 due to increasing aging population and rising prevalence of chronic illnesses.

The List of Companies - Australia and New Zealand Remote Healthcare Market

  1. BIOTRONIK SE & Co KG
  2. Koninklijke Philips NV
  3. Hicuity Health Inc
  4. Medtronic Plc
  5. American Well Corp
  6. Teladoc Health Inc
  7. BioTelemetry Inc
  8. Abbott Laboratories
  9. GE HealthCare
  10. Siemens Healthcare GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Australia and New Zealand Remote Healthcare Market